This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Crossover Comparison With Fluphenazine

David Pickar, MD; Richard R. Owen, MD; Robert E. Litman, MD; P. Eric Konicki, MD; Rolando Gutierrez, MD; Mark H. Rapaport, MD

Arch Gen Psychiatry. 1992;49(5):345-353.

Abstract
• Twenty-one patients with schizophrenia who met criteria for neuroleptic treatment resistance or intolerance participated in a crossover, placebo-controlled, double-blind comparison of long-term typical neuroleptic and clozapine treatment. Clozapine significantly reduced total as well as positive and negative symptoms in comparison with both fluphenazine and placebo. Of the 21 patients, eight (38%) showed clozapine superiority on the basis of prospective response criteria. High levels of extrapyramidal side effects during fluphenazine treatment and later onset of illness were clinical predictors of clozapine superiority. Clozapine and fluphenazine equally reduced plasma homovanillic acid levels in comparison with placebo, although fluphenazine but not clozapine increased plasma prolactin level. A striking biologic difference between clozapine and fluphenazine was clozapine's enhancement of indexes of noradrenergic activity. Superior clozapine response was predicted by low ratios of cerebrospinal fluid homovanillic acid to 5-hydroxyindoleacetic acid, consistent with the notion that balance between dopaminergic and serotoninergic systems is important for clozapine's mechanism of action.

Author Affiliations
From the Section on Clinical Studies, Experimental Therapeutics Branch, National Institute of Mental Health, Bethesda, Md.

Footnotes
Accepted for publication October 9, 1991.

Reprint requests to Section on Clinical Studies, Experimental Therapeutics Branch, National Institute of Mental Health, National Institutes of Health, Bldg 10, Room 4N214, 9000 Rockville Pike, Bethesda, MD 20892 (Dr Pickar).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment
McEvoy et al.
Am. J. Psychiatry 2006;163:600-610.
ABSTRACT | FULL TEXT  

Equivalent Occupancy of Dopamine D1 and D2 Receptors With Clozapine: Differentiation From Other Atypical Antipsychotics
Tauscher et al.
Am. J. Psychiatry 2004;161:1620-1625.
ABSTRACT | FULL TEXT  

The Relationship of Clozapine and Haloperidol Treatment Response to Prefrontal, Hippocampal, and Caudate Brain Volumes
Arango et al.
Am. J. Psychiatry 2003;160:1421-1427.
ABSTRACT | FULL TEXT  

Effect Size of Symptom Status in Withdrawal of Typical Antipsychotics and Subsequent Clozapine Treatment in Patients With Treatment-Resistant Schizophrenia
Pickar and Bartko
Am. J. Psychiatry 2003;160:1133-1138.
ABSTRACT | FULL TEXT  

A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis et al.
Arch Gen Psychiatry 2003;60:553-564.
ABSTRACT | FULL TEXT  

Clozapine and Haloperidol in Moderately Refractory Schizophrenia: A 6-Month Randomized and Double-blind Comparison
Kane et al.
Arch Gen Psychiatry 2001;58:965-972.
ABSTRACT | FULL TEXT  

Biperiden for Excessive Sweating From Clozapine
RICHARDSON et al.
Am. J. Psychiatry 2001;158:1329-1330.
FULL TEXT  

Impact of Clozapine on Completed Suicide
Sernyak et al.
Am. J. Psychiatry 2001;158:931-937.
ABSTRACT | FULL TEXT  

A Separate Disease Within the Syndrome of Schizophrenia
Kirkpatrick et al.
Arch Gen Psychiatry 2001;58:165-171.
ABSTRACT | FULL TEXT  

Psychopharmacologic Treatment Strategies for Depression, Bipolar Disorder, and Schizophrenia
Glick et al.
ANN INTERN MED 2001;134:47-60.
ABSTRACT | FULL TEXT  

Clozapine Treatment of Outpatients With Schizophrenia: Outcome and Long-Term Response Patterns
Breier et al.
Psychiatr. Serv. 2000;51:1249-1253.
FULL TEXT  

Refractory schizophrenia and atypical antipsychotics
Taylor et al.
J Psychopharmacol 2000;14:409-418.
ABSTRACT  

Clozapine and Risperidone in Chronic Schizophrenia: Effects on Symptoms, Parkinsonian Side Effects, and Neuroendocrine Response
Breier et al.
Am. J. Psychiatry 1999;156:294-298.
ABSTRACT | FULL TEXT  

Impact of Clozapine on Negative Symptoms and on the Deficit Syndrome in Refractory Schizophrenia
Rosenheck et al.
Am. J. Psychiatry 1999;156:88-93.
ABSTRACT | FULL TEXT  

Olanzapine Compared With Chlorpromazine in Treatment-Resistant Schizophrenia
Conley et al.
Am. J. Psychiatry 1998;155:914-920.
ABSTRACT | FULL TEXT  

Positive and Negative Symptom Response to Clozapine in Schizophrenic Patients With and Without the Deficit Syndrome
Buchanan et al.
Am. J. Psychiatry 1998;155:751-760.
ABSTRACT | FULL TEXT  

Risperidone Versus Clozapine in Treatment-Resistant Chronic Schizophrenia: A Randomized Double-Blind Study
Bondolfi et al.
Am. J. Psychiatry 1998;155:499-504.
ABSTRACT | FULL TEXT  

Childhood-Onset Schizophrenia
Bhatara et al.
Arch Gen Psychiatry 1998;55:90-92.
FULL TEXT  

A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory Schizophrenia
Rosenheck et al.
NEJM 1997;337:809-815.
ABSTRACT | FULL TEXT  

The Brain Metabolic Patterns of Clozapine- and Fluphenazine-Treated Patients With Schizophrenia During a Continuous Performance Task
Cohen et al.
Arch Gen Psychiatry 1997;54:481-486.
ABSTRACT  

Atypical Antipsychotics and the Pharmacology of Olanzapine
Nihart
J Am Psychiatr Nurses Assoc 1997;3:S2-S7.
ABSTRACT  

Noradrenergic mechanisms in the prefrontal cortex
Nutt et al.
J Psychopharmacol 1997;11:163-168.
ABSTRACT  

Childhood-Onset Schizophrenia: A Double-blind Clozapine-Haloperidol Comparison
Kumra et al.
Arch Gen Psychiatry 1996;53:1090-1097.
ABSTRACT  

Clozapine: Serious Adverse Side Effects, Drug Interactions, and Other Complications of Therapy
Guith
Journal of Pharmacy Practice 1996;9:118-129.
ABSTRACT  

Clozapine for Treatment of Schizophrenia-Reply
Pickar
JAMA 1996;275:187-187.
ABSTRACT  

Clozapine Treatment of Schizophrenia
Pickar and Hsiao
JAMA 1995;274:981-983.
ABSTRACT  

Clozapine Therapy and Increases in Homovanillic Acid
Risch and Lewine
Arch Gen Psychiatry 1995;52:244-244.
ABSTRACT  

Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine
Rao et al.
Arch Gen Psychiatry 1994;51:912-917.
ABSTRACT  

Schizophrenia
Carpenter and Buchanan
NEJM 1994;330:681-690.
FULL TEXT  

Clinical Response to Clozapine in Patients With Schizophrenia
Pickar et al.
Arch Gen Psychiatry 1994;51:159-160.
ABSTRACT  

No Structural Mutation in the Dopamine D2 Receptor Gene in Alcoholism or Schizophrenia: Analysis Using Denaturing Gradient Gel Electrophoresis
Gejman et al.
JAMA 1994;271:204-208.
ABSTRACT  

Putting the 'A' in atypical: does {alpha}2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?
Nutt
J Psychopharmacol 1994;8:193-195.
 

L-dopa helps positive but not negative features of neuroleptic-insensitive chronic schizophrenia
Owens et al.
J Psychopharmacol 1994;8:204-212.
ABSTRACT  

Muscarinic Effects of Clozapine and Negative Symptoms
Keshavan
Arch Gen Psychiatry 1993;50:835-835.
ABSTRACT  

Progress in Psychiatry- First of Two Parts
Michels and Marzuk
NEJM 1993;329:552-560.
FULL TEXT  

Effects of Clozapine and Fluphenazine Treatment on Responses to m-Chlorophenylpiperazine Infusions in Schizophrenia
Owen et al.
Arch Gen Psychiatry 1993;50:636-644.
ABSTRACT  

Low Cerebrospinal Fluid Homovanillic Acid-5-Hydroxyindoleacetic Acid Ratio Predicts Clozapine Efficacy: A Replication
Risch and Lewine
Arch Gen Psychiatry 1993;50:670-670.
ABSTRACT  

Neuropharmacologic Basis for Clozapine's Unique Profile
Tandon and Kane
Arch Gen Psychiatry 1993;50:158-159.
ABSTRACT